FIELD: biotechnology.
SUBSTANCE: methods for detection of a human IgE isotype antibody against omalizumab are provided. Sets, methods for identification of a patient at risk of an anaphylactic reaction to omalizumab, and a method for treatment of a patient with an IgE-mediated disorder are also contemplated.
EFFECT: invention allows timely detection of allergic reactions to omalizumab and can be used in therapy and prevention of anaphylaxis.
52 cl, 27 dwg, 7 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
FcγRIIB RECEPTOR ANTIBODIES AND APPLICATION THEREOF | 2005 |
|
RU2404991C2 |
ANTI-IGE ANTIBODIES | 2017 |
|
RU2816207C2 |
APOPTOTIC ANTIBODIES AGAINST IgE | 2008 |
|
RU2500686C2 |
NOVEL ANTIBODIES | 2008 |
|
RU2490277C2 |
COMPOSITION CONTAINING PROBIOTICS AND POLYPEPTIDE HAVING BINDING AFFINITY RELATIVELY TO IgE AND ITS USE | 2019 |
|
RU2786578C2 |
MULTISPECIFIC ANTIBODIES, THEREOF ANALOGUES, COMPOSITIONS AND METHODS | 2010 |
|
RU2580038C2 |
IMPROVED ANTI-IGE-ANTIBODY (VARIANTS) AND METHOD FOR IMPROVING POLYPEPTIDES | 1998 |
|
RU2242515C2 |
ANTIBODIES AGAINST NOTCH2 AND METHODS FOR APPLICATION THEREOF | 2009 |
|
RU2580029C2 |
ANTIBODIES AGAINST FGFR3 AND METHODS OF THEIR APPLICATION | 2010 |
|
RU2568066C2 |
OX40L ANTIBODIES AND METHODS FOR USING | 2006 |
|
RU2426744C2 |
Authors
Dates
2018-01-24—Published
2010-10-26—Filed